84
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization :

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To compare self-reported maternal marijuana use to quantitative biological sampling for a marijuana metabolite, 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH), in umbilical cord homogenate in a state with legalized marijuana. Cross-sectional study of women approached at time of admission for delivery with live, singleton pregnancies ≥ 24 weeks at two urban medical centers in Colorado. Maternal marijuana use was estimated by (1) report to health care provider on admission history and physical, (2) survey of self-reported use, and (3) liquid chromatography tandem mass spectrometry analysis of umbilical cord homogenate for THC-COOH. Women were categorized by survey-reported last use (≤30 days ago, 30 days to 1 year, more than 1 year, never), and proportion of women with cord results above the limit of detection and limit of quantification for THC-COOH was reported for each group. Comparisons between groups were made using contingency tables. Correlation between survey-reported frequency of use and quantitative THC-COOH cord homogenate results was evaluated. We included 116 women with self-report surveys linked to cord assay results. Six percent (95% CI 2.5–12.0%) of participants reported use in the last 30 days on survey and 2.6% (95% CI 0.5–7.4%) of participants reported marijuana use to health care providers. On umbilical cord assay, 22.4% (95% CI 15.2–31.1%) had detectable THC-COOH. The proportion of women with detectable THC-COOH increased with more recent self-reported use. Survey-reported frequency of use in the past 30 days had moderate correlation with quantified umbilical cord THC-COOH (correlation coefficient 0.44, 95% CI 0.28–0.58, p<0.001). Umbilical cord sampling results in higher estimates of prenatal marijuana use than self-report even in the setting of legalization. Umbilical cord assays for THC-COOH demonstrate promise for quantifying use. Future studies should examine how the use of biological sampling informs the association between marijuana use and perinatal outcomes. Umbilical cord sampling for marijuana metabolites detected prenatal marijuana use at a higher rate than self-reported estimates even in a state with legalized marijuana.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: not found
          • Article: not found

          Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Committee Opinion No. 722

              (2017)
              Cannabis sativa (marijuana) is the illicit drug most commonly used during pregnancy. The self-reported prevalence of marijuana use during pregnancy ranges from 2% to 5% in most studies. A growing number of states are legalizing marijuana for medicinal or recreational purposes, and its use by pregnant women could increase even further as a result. Because of concerns regarding impaired neurodevelopment, as well as maternal and fetal exposure to the adverse effects of smoking, women who are pregnant or contemplating pregnancy should be encouraged to discontinue marijuana use. Obstetrician-gynecologists should be discouraged from prescribing or suggesting the use of marijuana for medicinal purposes during preconception, pregnancy, and lactation. Pregnant women or women contemplating pregnancy should be encouraged to discontinue use of marijuana for medicinal purposes in favor of an alternative therapy for which there are better pregnancy-specific safety data. There are insufficient data to evaluate the effects of marijuana use on infants during lactation and breastfeeding, and in the absence of such data, marijuana use is discouraged.
                Bookmark

                Author and article information

                Journal
                Obstetrics & Gynecology
                Obstetrics & Gynecology
                Ovid Technologies (Wolters Kluwer Health)
                0029-7844
                2019
                January 2019
                : 133
                : 1
                : 98-104
                Article
                10.1097/AOG.0000000000003028
                6370297
                30531577
                adf8a280-5de0-4c4e-b177-8b79835eb277
                © 2019
                History

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content3,098

                Cited by28

                Most referenced authors179